Farmak JSC, the leader of Ukrainian pharmaceutical market continues to expand its ENT product portfolio and bring new medicinal products to the market. Thus, a new medicinal product Ototon in the form of ear drops (16 g) was added to Farmak's product portfolio.
Ototon is used for local symptomatic treatment and pain relief for diseases of the middle ears when the eardrum is intact:
Ototon is a combination of 2 active pharmaceutical ingredients: phenazone and lidocaine, which have pronounced analgesic and anti-inflammatory effect.
This medicinal product starts to have its effect in as little as 5 minutes after dropping. The pain syndrome disappears almost completely in 15-30 minutes.
This medicinal product can be prescribed to adult patients and children 4 drops 2-3 times a day.
If required, Ototon can be used during pregnancy, breast-feeding, and for breast-fed children after consultation with a doctor.
TOP 100. The Ratings of the Largest published the Employer Brand Rating and the Rating of TOP 30 Best HR Directors in Ukraine. According to the magazine, Farmak is one of three companies providing the best working conditions, and Viktoria Kondrashykhina, HR Director of Farmak, became the best HR director in the pharmaceutical industry. The […]
CEO of Farmak took part in a panel discussion during Kyiv Investment Forum “Local Business Development: from manufacturer to end consumer” and presented the components of successful business Paolo Di Croce, Secretary General of Slow Food International, Olha Mahaletska, Head of the Office of the National Investment Council, Iryna Danylevska, UFW Founder &...
The teams of Farmak, Alfa-Bank Ukraine, DTEK, Energoatom, FUIB, Astarta-Kyiv, EPAM, EY Ukraine, FILM.UA Group presented their projects of Integration of Sustainable Development Goals in existing business models at the final event of the international Young SDG Innovators Programme launched by the UN Global Compact. The event gathered together 148 team...